BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7621266)

  • 1. [Acute renal failure associated with 5-aminosalicylic acid in inflammatory bowel disease].
    García-Díaz M; Nevado L; Berenguer A; Bureo JC; Bureo P; Sáenz de Santamaría J
    Gastroenterol Hepatol; 1995 Jan; 18(1):18-21. PubMed ID: 7621266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
    Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
    Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic inflammatory intestinal disease and nephritis].
    Behrens R; Ruder H
    Klin Padiatr; 1992; 204(1):61-4. PubMed ID: 1346814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
    Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
    Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute tubular necrosis with acute renal failure during the first month of treatment with 5-amino-salicylate (Pentasa(R))].
    Beaulieu S; Rocher P; Hillion D; Nochy D; Tennenbaum R; Vitte RL; Eugène C
    Gastroenterol Clin Biol; 2002 Apr; 26(4):412-4. PubMed ID: 12070416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Aminosalicylic acid-associated renal tubular acidosis with decreased renal function in Crohn's disease.
    Hämling J; Raedler A; Helmchen U; Schreiber S
    Digestion; 1997; 58(3):304-7. PubMed ID: 9243128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tubulo-interstitial nephritis in inflammatory bowel disease: extra-intestinal manifestation or drug toxicity?].
    Heidt J; Ooms EC; van der Werf SD; Groeneveld JH
    Ned Tijdschr Geneeskd; 2010; 154():A1647. PubMed ID: 20699041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
    Netzer P
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mesalazine].
    Netzer P
    Dtsch Med Wochenschr; 1996 Jan; 121(1-2):42. PubMed ID: 8565806
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pentasa (mesalazine) and pregnancy].
    Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
    Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic interstitial nephritis induced by 5-aminosalicylic acid: a new case report].
    Laboudi A; Makdassi R; Cordonnier C; Fournier A; Choukroun G
    Nephrologie; 2002; 23(7):343-7. PubMed ID: 12500420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
    Glintborg B
    Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mesalazine and sulphasalazine for Crohn's disease: few indications, severe adverse reactions].
    Uittenbogaart SB; Klemt-Kropp M
    Ned Tijdschr Geneeskd; 2011; 155(48):A3842. PubMed ID: 22152414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Severe chronic interstitial nephritis associated with Crohn's disease, but not with mesalazine?].
    Baumer P; Brocard JF; Kohn W; Bedossa P; Charpentier B
    Gastroenterol Clin Biol; 1999 Dec; 23(12):1400-2. PubMed ID: 10642629
    [No Abstract]   [Full Text] [Related]  

  • 16. [Association between membranous glomerulonephritis and Crohn's disease].
    Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
    Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfasalazine, 5-ASA and acute pancreatitis in crohn's disease.
    Debongnie JC; Dekoninck X
    J Clin Gastroenterol; 1994 Dec; 19(4):348-9. PubMed ID: 7876525
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pericardial effusion during the therapy of Crohn's disease with 5-aminosalicylic acid].
    Weber P; Becker EW; Jenss H
    Dtsch Med Wochenschr; 1988 Nov; 113(46):1806-7. PubMed ID: 3191853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute pancreatitis due to 5-aminosalicylic acid].
    Romero Castro R; Jiménez Sáenz M; Pellicer Bautista FJ; Domínguez Palomo S; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 1991 Mar; 79(3):219-21. PubMed ID: 2043409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute interstitial nephritis due to mesalazine.
    Tadic M; Grgurevic I; Scukanec-Spoljar M; Bozic B; Marusic S; Horvatic I; Galesic K
    Nephrology (Carlton); 2005 Apr; 10(2):103-5. PubMed ID: 15877665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.